Cost-Effectiveness of Crizotinib for First-Line Treatment in Non-Small Cell Lung Cancer in Ecuador
May 1, 2018, 00:00
10.1016/j.jval.2018.04.202
https://www.valueinhealthjournal.com/article/S1098-3015(18)30502-3/fulltext
Title :
Cost-Effectiveness of Crizotinib for First-Line Treatment in Non-Small Cell Lung Cancer in Ecuador
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30502-3&doi=10.1016/j.jval.2018.04.202
First page :
Section Title :
Open access? :
No
Section Order :
1055